SRI International

SRI International has updated its BioCyc database collection to include a mobile application for remote access, as well as additional repositories that support researchers studying genomes and metabolic pathways.

NEW YORK (GenomeWeb News) – SRI International and Spyglass Technologies today announced an exclusive licensing deal to commercialize SRI's underwater mass spectrometry technology.

NEW YORK (GenomeWeb News) – SRI International on Monday said that the National Heart, Lung, and Blood Institute awarded it a $4.5 million contract to establish a center aimed at improving metabolomics research.

NEW YORK (GenomeWeb News) – Agilent Technologies and SRI International today announced a licensing agreement to offer a series of Agilent's products with SRI's complete BioCyc Pathway Database Collection.

Ingenuity has released iReport, a reporting tool for statistical analysis and biological interpretation of gene expression data.

Downloads & Upgrades

Premium

IO Informatics has launched Knowledge Explorer 3.6, an upgrade of its flagship data-management platform.

SRI and CCD will develop computational tools for a tuberculosis information repository that could help researchers create new TB treatments.

Movers & Shakers

Premium

Ruedi Aebersold, Anne Ferguson-Smith, Jeannie Lee, Diane Mathis, Dave Anderson, William Thomsen, Jens Holstein, Dave Lemus

SRI will use the funds to add energy-related metabolic pathways and enzymes to its MetaCyc database. The updated content, combined with its Pathway Tool software, will help scientists reconstruct metabolic pathways and develop new methods of producing fuel and other products from biomass and microorganisms.

The money is part of the $22 million committed by the state in return for the nonprofit research and technology development institute locating its recently-opened Center for Advanced Drug Research, or CADRE, in Harrisonburg, Va.

Pages

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.